Article
Pulse doses of oral agent may help stabilize inflammatory acne
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
FDA Places Clinical Hold on VYNE’s VYN202 Phase 1b Trial for Plaque Psoriasis
Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
Stopping Adjuvant Immunotherapy Early May Not Worsen Outcomes in Resected Metastatic Melanoma
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Upadacitinib Outpaces Dupilumab in Rapid AD Symptom Control
Managing Wound Risks in Patients on TKIs